[1] Beers M and Berkow R. The Merck Manual 17th Ed. 1999. Pages: 307-312.

[2] Beers M and Berkow R. The Merck Manual 17th Ed. 1999. Pages: 307-312.

[3] www.nddic.com National Digestive Disease Information Clearinghouse. November 2004.

[4] Beers M and Berkow R. The Merck Manual 17th Ed. 1999. Pages: 307-312.

[5] www.nddic.com National Digestive Disease Information Clearinghouse. November 2004.

[6] www.ccfa.org Crohn's and Colitis Foundation of America. November 2004.

[7] www.nih.gov National Institute of Health. November 2004.

[8] Barbosa DS et al. Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil omega 3 fatty acids. Nutrition. 2003 Oct; 19(10): 837-842.

[9] Aslan A and Triadafilopoulos G. Fish oil fatty acids in active ulcerative colitis: a double blind placebo controlled crossover study. Am J Gastroenterol. 1992 Apr; 87(4): 432-437.

[10] Loeschke K et al. N-3 fatty acids only delay early relapse of ulcerative colitis in remission. Dig Dis Sci. 1996 Oct; 41(10): 2087-2094.

[11] Greenfield SM et al. A randomized controlled study of evening primrose oil and fish oils in ulcerative colitis. Aliment Pharmacol Ther. 1993 Apr; 7(2): 159-166.

[12] Biasco G et al. Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis. Cancer Epidemiol Biomarkers Prev. 1997 Jun; 6(6): 469-471.

[13] Langmead L et al. Randomized double blind placebo controlled trial of aloe Vera gel for active ulcerative colitis. Aliment Pharmacol Ther. 2004 Apr; 19(7): 739-747.

[14] Andus T et al. Patients with refractory Crohn's disease or ulcerative colitis respond to dehydroepiandrosterone: a pilot study. Ailment Pharmacol Ther. 2003 Feb; 17(3): 409-414.

[15] Abitbol V et al. Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluorine. Aliment Pharmacol Ther. 2002 May; 16(5): 919-927.

 

Return to Ulcerative Colitis Introduction